Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis
Clinical trial NCT05116540 · COMPLETED
Trial details
- NCT number
- NCT05116540
- Sponsor
- Hope Biosciences Research Foundation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-24
- Primary completion
- 2024-06-04
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.